カテゴリー： 世界, 医療/バイオ, IMARC

世界の脈絡膜新生血管市場予測2023年-2028年

【英語タイトル】Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが出版した調査資料（IMARC23DCB0254）・商品コード：IMARC23DCB0254
・発行会社（調査会社）：IMARC
・発行日：2023年11月
・ページ数：139
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

世界の脈絡膜新生血管の市場規模は2022年に60億ドルに達しました。今後、IMARC Groupは、市場が2028年までに95億ドルに達し、2022年から2028年の間に8.0%の成長率（CAGR）を示すと予測しています。
脈絡膜新生血管（CNV）とは、ブルッフ膜や網膜色素上皮（RPE）に影響を及ぼす眼の脈絡膜層に新生血管が生じることを指す。その症状には、脂質の滲出、網膜下の血液や液体、中心視野のゆがみ、うねり、黒点などがあります。現在、CNVの診断には、フルオレセイン血管造影（FA）、インドシアニングリーン（ICG）血管造影、光干渉断層計（OCT）スキャンなどの検査が併用されています。その結果に応じて、医師は抗血管内皮増殖因子（VEGF）薬、熱レーザー治療、光線力学的療法（PDT）を処方し、血管の成長を防ぐ。

加齢黄斑変性（ARMD）、眼ヒストプラスマ症、病的近視、血管筋、脈絡膜断裂、脈絡膜と網膜の炎症性疾患の有病率の上昇により、市場は成長を遂げています。さらに、深刻な健康状態に陥りやすい老年人口の増加が、市場の成長を後押しするもう1つの重要な要因となっています。さらに、長期持続型抗VEGF薬の導入とともに、併用薬の採用が増加していることも、CNV治療に対する世界的な需要を後押ししています。医療インフラの改善や研究開発（R&D）活動への投資の増加など、その他の要因も市場の成長に寄与しています。

主な市場セグメンテーション
IMARC Groupは、世界の脈絡膜新生血管市場レポートの各サブセグメントにおける主要動向の分析を、2023年から2028年までの世界、地域、国レベルでの予測とともに提供しています。当レポートでは、製品タイプ、診断タイプ、治療タイプ、用途に基づいて市場を分類しています。

製品タイプ別内訳：静脈内
硝子体内

診断タイプ別内訳
フルオレセイン血管造影（FA）
インドシアニングリーン（ICG）血管造影法
スペクトルドメイン光干渉断層計（OCT）
その他

治療タイプ別内訳：
血管新生阻害剤 注射
光線力学的療法
レーザー光凝固療法
低線量放射線療法
手術療法

用途別内訳：極度の近視
悪性近視変性
加齢関連開発

地域別構成比：北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争状況
本レポートでは、市場の競争環境についても分析しており、主なプレーヤーとしては、Bausch Health Companies Inc.、Bayer AG、Gilead Sciences、Inc.、F. Hoffmann-La Roche AG、MaaT Pharma、Novartis AG、Pfizer Inc.、Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited)、Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).などの企業が挙げられます。

本レポートで回答した主な質問
世界の脈絡膜新生血管形成市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
COVID-19が世界の脈絡膜新生血管形成市場に与えた影響は？
主要な地域市場は？
製品タイプに基づく市場の内訳は？
診断のタイプに基づく市場の内訳は？
治療タイプ別の市場内訳は？
アプリケーションに基づく市場の内訳は？
業界のバリューチェーンにおける様々な段階とは？
業界の主要な推進要因と課題は何か？
世界の脈絡膜新生血管形成市場の構造と主要プレイヤーは？
業界における競争の程度は？

1. 序論
2. 範囲・調査手法
3. エグゼクティブサマリー
4. イントロダクション
5. 世界の脈絡膜新生血管市場
6. 脈絡膜新生血管の世界市場規模：製品タイプ別
7. 脈絡膜新生血管の世界市場規模：診断タイプ別
8. 脈絡膜新生血管の世界市場規模：治療別
9. 脈絡膜新生血管の世界市場規模：用途別
10. 脈絡膜新生血管の世界市場規模：地域別
11. SWOT分析
12. バリューチェーン分析
13. ファイブフォース分析
14. 価格分析
15. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Choroidal Neovascularization Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Intravenous
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intravitreal
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Type of Diagnosis
7.1 Fluorescein Angiography (FA)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Indocyanine Green (ICG) Angiography
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Spectral Domain Optical Coherence Tomography (OCT)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Treatment Type
8.1 Angiogenesis Inhibitors Injection
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Photodynamic Therapy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Laser Photocoagulation
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Low-dose Radiation Therapy
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Surgery
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Application
9.1 Extreme Myopia
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Malignant Myopic Degeneration
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Age-Related Developments
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bausch Health Companies Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Bayer AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Gilead Sciences, Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche AG
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 MaaT Pharma
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Novartis AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Pfizer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Regeneron Pharmaceuticals Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio

Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2022
Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2022
Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2022
Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2022
Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
Figure 87: Global: Choroidal Neovascularization Industry: Porter’s Five Forces Analysis

Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2023-2028
Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Choroidal Neovascularization Market Structure
Table 8: Global: Choroidal Neovascularization Market: Key Players

★調査レポート[世界の脈絡膜新生血管市場予測2023年-2028年] (コード：IMARC23DCB0254)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の脈絡膜新生血管市場予測2023年-2028年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のモノクローナル抗体市場予測2022年-2028年
  • 世界の血液悪性腫瘍市場予測2023年-2028年
  • 世界の臨床栄養市場予測2023年-2028年
  • 世界の血液浄化装置市場予測2023年-2028年
  • 世界の生物製剤市場予測2023年-2028年
  • 世界の消化管治療薬市場予測2023年-2028年
  • 世界の早期毒性試験市場予測2023年-2028年
  • 世界の高脂血症治療薬市場予測2023年-2028年
  • 世界のスタチン市場予測2023年-2028年
  • 世界のプレフィルドシリンジ市場予測2023年-2028年

    • ◆H&Iグローバルリサーチのお客様（例）◆